Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19.
Saved in:
| Title: | Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19. |
|---|---|
| Authors: | Valdez‑Cruz, Norma A.1,2 (AUTHOR) adri@iibiomedicas.unam.mx, Rosiles-Becerril, Diego1 (AUTHOR), Martínez-Olivares, Constanza E.1 (AUTHOR), García‑Hernández, Enrique3 (AUTHOR), Cobos-Marín, Laura4 (AUTHOR), Garzón, Daniel5 (AUTHOR), López-Salas, Francisco E.1 (AUTHOR), Zavala, Guadalupe6 (AUTHOR), Luviano, Axel7 (AUTHOR), Olvera, Alejandro8 (AUTHOR), Alagón, Alejandro8 (AUTHOR), Ramírez, Octavio T.8 (AUTHOR), Trujillo‑Roldán, Mauricio A.1,2 (AUTHOR) maurotru@iibiomedicas.unam.mx |
| Source: | Microbial Cell Factories. 2/6/2024, Vol. 23 Issue 1, p1-22. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
